Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Cancer Supportive Care Drugs Market to reach USD 24.20 billion by the end of 2030.

Global Cancer Supportive Care Drugs Market Size study & Forecast, by Type ( ESA, G-CSFs, Antiemetics, Bisphosphonates, Opioids, Others) by Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Others), by Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Providers) and Regional Analysis, 2023-2030

Product Code: HLSDT-93005078
Publish Date: 4-08-2023
Page: 200

Global Cancer Supportive Care Drugs Market is valued at approximately USD 20.50 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 2.2% over the forecast period 2023-2030. Cancer supportive care drugs, also known as palliative care drugs, are medications used to manage the symptoms and side effects of cancer and its treatments. These drugs are designed to improve the quality of life for cancer patients by alleviating pain, reducing treatment-related complications, and addressing various physical and emotional challenges that arise during the disease. The Cancer Supportive Care Drugs Market is expanding because of factors such as the rising prevalence of cancer, and rising government funding for drug development.

The rising prevalence of cancer globally is fostering market growth, according to estimates from the International Agency for Research on Cancer (IARC), The estimated increase in the worldwide burden of cancer is 27.5 million new cases by 2040 from 1.9 million new cases in year 2021.Furthermore, increasing disposable income as well as improved healthcare structure has also helped people to access cancer supportive care drugs, which is also helping this market grow. For instance, according to an update from August 2021, MediShield Life coverage in Singapore went from paying USD 3,000 per month to a range of USD 200 to USD 9,600 per month, depending on the medications used. Along with increasing the eligibility requirements for Medication Assistance Fund subsidies for some expensive medications from USD 2,800 to USD 6,500, the government would also subsidize more cancer treatments. In addition, the increase in R&D and several pipeline cancer supportive care drugs and the surge in the global geriatric population are creating lucrative growth in the market. However, the high cost of Cancer Supportive Care Drugs stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Cancer Supportive Care Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of key market player, rising prevelance of cancer disease in the region, and rising development of new cancer drugs in the region. Asia Pacific is expected to grow at a fastest rate during the forecast period, owing to factors such as rising prevelance of cancer, rising funding and investment on research and development activities and rising government support to the industry.

Major market player included in this report are:
Amgen Inc.
Baxter International Inc.
F Hoffmann-La Roche Ltd.
Glaxosmithkline Plc (Gsk) (Tesasro)
Heron Therapeutics Inc
Johnson & Johnson (Janssen Global Services, Llc,)
Merck Kgaa
Novartis International Ag (Sandoz)
Teva Pharmaceuticals Industries Ltd
Helsinn Healthcare SA

Recent Developments in the Market:
Ø In March 2022, Australian-based Imugene announced a new clinical trial partnership and supply agreement with MSD, a brand name of Merck & Co., Inc., Kenilworth, NJ, USA, to test the safety and effectiveness of Imugene’s HER-Vaxx, a B-cell activating immunotherapy, in combination with MSD’s anti-PD-1 therapy, pembrolizumab (KEYTRUDA), in patients with HER-2 positive gastric cancer.
Ø In March 2022, Pluvicto from Novartis has been authorised by the US Food and Drug Administration (FDA) to treat people with this specific cancer type. These patients have already had androgen receptor pathway inhibition and taxane-based chemotherapy.
Global Cancer Supportive Care Drugs Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Type, Application, Distribution Channel, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Type offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
ESA (Erythropoiesis-Stimulating Agents)
G-CSFs (Granulocyte Colony-Stimulating Factors)
Antiemetics
Bisphosphonates
Opioids
NSAIDs (Non-Steroidal Auto Inflammatory Drugs)
Others

By Application:
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Liver Cancer
Stomach Cancer
Others
By Distribution Channel:
Hospital Pharmacies
Drug Stores and Retail Pharmacies
Online Providers

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Cancer Supportive Care Drugs Market, by Region, 2020-2030 (USD Billion)
1.2.2. Cancer Supportive Care Drugs Market, by Type, 2020-2030 (USD Billion)
1.2.3. Cancer Supportive Care Drugs Market, by Application, 2020-2030 (USD Billion)
1.2.4. Cancer Supportive Care Drugs Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cancer Supportive Care Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cancer Supportive Care Drugs Market Dynamics
3.1. Cancer Supportive Care Drugs Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of cancer
3.1.1.2. Rising government funding for drugs development
3.1.2. Market Challenges
3.1.2.1. High Cost of Cancer Supportive Care Drugs
3.1.3. Market Opportunities
3.1.3.1. Increase in R&D and number of pipeline cancer supportive care drugs
3.1.3.2. Surge in global geriatric population
Chapter 4. Global Cancer Supportive Care Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Cancer Supportive Care Drugs Market, by Type
5.1. Market Snapshot
5.2. Global Cancer Supportive Care Drugs Market by Type, Performance – Potential Analysis
5.3. Global Cancer Supportive Care Drugs Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
5.4. Cancer Supportive Care Drugs Market, Sub Segment Analysis
5.4.1. ESA (Erythropoiesis-Stimulating Agents)
5.4.2. ESA (Erythropoiesis-Stimulating Agents)
5.4.3. G-CSFs (Granulocyte Colony-Stimulating Factors)
5.4.4. Antiemetics
5.4.5. Bisphosphonates
5.4.6. Opioids
5.4.7. NSAIDs (Non-Steroidal Auto Inflammatory Drugs)
5.4.8. Others
5.4.9.
Chapter 6. Global Cancer Supportive Care Drugs Market, by Application
6.1. Market Snapshot
6.2. Global Cancer Supportive Care Drugs Market by Application, Performance – Potential Analysis
6.3. Global Cancer Supportive Care Drugs Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Cancer Supportive Care Drugs Market, Sub Segment Analysis
6.4.1. Breast Cancer
6.4.2. Lung Cancer
6.4.3. Colorectal Cancer
6.4.4. Prostate Cancer
6.4.5. Liver Cancer
6.4.6. Stomach Cancer
6.4.7. Others
Chapter 7. Global Cancer Supportive Care Drugs Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Cancer Supportive Care Drugs Market by Distribution Channel, Performance – Potential Analysis
7.3. Global Cancer Supportive Care Drugs Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
7.4. Cancer Supportive Care Drugs Market, Sub Segment Analysis
7.4.1. Hospital Pharmacies
7.4.2. Drug Stores and Retail Pharmacies
7.4.3. Online Providers
Chapter 8. Global Cancer Supportive Care Drugs Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Cancer Supportive Care Drugs Market, Regional Market Snapshot
8.4. North America Cancer Supportive Care Drugs Market
8.4.1. U.S. Cancer Supportive Care Drugs Market
8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
8.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Cancer Supportive Care Drugs Market
8.5. Europe Cancer Supportive Care Drugs Market Snapshot
8.5.1. U.K. Cancer Supportive Care Drugs Market
8.5.2. Germany Cancer Supportive Care Drugs Market
8.5.3. France Cancer Supportive Care Drugs Market
8.5.4. Spain Cancer Supportive Care Drugs Market
8.5.5. Italy Cancer Supportive Care Drugs Market
8.5.6. Rest of Europe Cancer Supportive Care Drugs Market
8.6. Asia-Pacific Cancer Supportive Care Drugs Market Snapshot
8.6.1. China Cancer Supportive Care Drugs Market
8.6.2. India Cancer Supportive Care Drugs Market
8.6.3. Japan Cancer Supportive Care Drugs Market
8.6.4. Australia Cancer Supportive Care Drugs Market
8.6.5. South Korea Cancer Supportive Care Drugs Market
8.6.6. Rest of Asia Pacific Cancer Supportive Care Drugs Market
8.7. Latin America Cancer Supportive Care Drugs Market Snapshot
8.7.1. Brazil Cancer Supportive Care Drugs Market
8.7.2. Mexico Cancer Supportive Care Drugs Market
8.8. Middle East & Africa Cancer Supportive Care Drugs Market
8.8.1. Saudi Arabia Cancer Supportive Care Drugs Market
8.8.2. South Africa Cancer Supportive Care Drugs Market
8.8.3. Rest of Middle East & Africa Cancer Supportive Care Drugs Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Amgen Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Baxter International Inc.
9.3.3. F Hoffmann-La Roche Ltd.
9.3.4. Glaxosmithkline Plc (Gsk) (Tesasro)
9.3.5. Heron Therapeutics Inc
9.3.6. Johnson & Johnson (Janssen Global Services, Llc,)
9.3.7. Merck Kgaa
9.3.8. Novartis International Ag (Sandoz)
9.3.9. Teva Pharmaceuticals Industries Ltd
9.3.10. Helsinn Healthcare SA
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now